Faro Health Inc.

1 open role

Faro Health builds software for the biopharma teams who design clinical trials, turning the protocol from a static Word document into structured data that can be analyzed, scored for patient burden and cost, and drafted with AI. The platform spans study design, protocol authoring, and startup workflow automation such as automated EDC builds, and a peer-reviewed paper applying it to Merck protocols quantified the savings from simplifying schedules of assessment. Founded in 2019 by a clinical operations leader and based in San Diego, it sells to pharma sponsors and raised a $20 million Series B led by General Catalyst. The team is still small, roughly 50 people, so product surface per person is wide.